Long-term Outcomes of May-Thurner Syndrome in Pediatric Patients
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 15-003644
Sponsor Protocol Number: 15-003644
About this study
The purpose of this study is to analyze thrombosis outcomes among pediatric patients with May-Thurner Syndrome who received stents or no vascular stents.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients 21 years of age or younger with confirmed diagnosis of May-Thurner Syndrome.
Exclusion Criteria:
- Patients with DVT not associated with May-Thurner Syndrome anatomic variant.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Vilmarie Rodriguez, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available